e-learning
resources
Virtual 2021
06.09.2021
Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - B cells are not involved in the regulation of adenoviral TGF-ß1- or bleomycin-induced lung fibrosis in mice
M. Moog (Hannover, Germany), C. Hinze (Hannover, Germany), L. Knudsen (Hannover, Germany), D. Deluca (Hannover, Germany), T. Welte (Hannover, Germany), M. Kolb (Hamilton, Canada), U. Maus (Hannover, Germany)
Source:
Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Session:
Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Session type:
E-poster
Number:
2380
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Moog (Hannover, Germany), C. Hinze (Hannover, Germany), L. Knudsen (Hannover, Germany), D. Deluca (Hannover, Germany), T. Welte (Hannover, Germany), M. Kolb (Hamilton, Canada), U. Maus (Hannover, Germany). Late Breaking Abstract - B cells are not involved in the regulation of adenoviral TGF-ß1- or bleomycin-induced lung fibrosis in mice. 2380
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Late Breaking Abstract - PRRX1 inhibition decreases fibrosis in the bleomycin-induced lung fibrosis model in mice
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018
Late Breaking Abstract - MIF inhibition in a murine model of bleomycin-induced lung fibrosis
Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension
Year: 2018
Late Breaking Abstract - Il24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing the m2 program in macrophages
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019
Late Breaking Abstract: The role of galectin-3 on macrophages in CNT-induced mouse lung inflammation
Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Year: 2010
Late Breaking Abstract - Loss of PTEN induces alveolar epithelial cell senescence resulting in lung fibrosis via activated NF-?B
Source: International Congress 2018 – ILDs: From bench to bedside
Year: 2018
Late Breaking Abstract - Caveolin-1 derived peptide LTI-03 promotes epithelial cell survival and attenuates pulmonary fibrosis
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019
Surface enolase-1 mediated cell migration and lung fibrosis in bleomycin-induced mice
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021
Late Breaking Abstract - WNT/ß-catenin signaling induces cellular senescence in lung alveolar epithelial cells
Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease
Year: 2019
Late Breaking Abstract - Hypoxia-induced cellular responses in lung fibroblasts from COPD patients and controls
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021
A role of Foxc2 gene in mice with bleomycin-induced pulmonary fibrosis
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
FGF-9 overexpression prevents pleural fibrosis induced by intra-pleural adenovirus injection in mice
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
The enhancement of Stanniocalcin-1 (STC1) secretion increases the ability of mesenchymal stem cells (MSCs) to reduce bleomycin-induced lung fibrosis in a mouse model through inhibition of endoplasmic reticulum stress (ER-stress)/TGFbeta1 pathway
Source: International Congress 2014 – ILDs 1
Year: 2014
Late Breaking Abstract - Aging impairs alveolar epithelial type II cell function in acute lung injury
Source: International Congress 2019 – Cellular metabolism and immune senescence in lung pathology
Year: 2019
The role of expression of TLR 4 in bleomycin-induced pulmonary fibrosis in mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Accelerating lung epithelial cell senescence in reduced CARM1 mice enhances elastase-induced emphysema
Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more
Year: 2014
Evolution of biomechanical changes in a murine model of bleomycin-induced lung fibrosis: inflammation
versus
fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 396s
Year: 2006
Reduction of lung injury and fibrosis by human embrionic stem cells in a mouse model of silica-induced lung fibrosis
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011
Targeting the hedgehog/GLI pathway decreases bleomycin-induced lung fibrosis
Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung
Year: 2013
Late Breaking Abstract - Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through systemic modulation of monocyte phenotypes
Source: International Congress 2018 – ILDs: From bench to bedside
Year: 2018
Regulation of immune cells in lung fibrosis: the reign of regnase-1?
Source: Eur Respir J, 57 (3) 2004029; 10.1183/13993003.04029-2020
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept